An open label trial of anakinra to prevent respiratory failure in COVID-19.

Evdoxia KyriazopoulouPeriklis PanagopoulosSymeon MetallidisGeorge N DalekosGaryphallia PoulakouNikolaos GatselisEleni KarakikeMaria SaridakiGeorgia LoliAggelos StefosDanai PrasianakiSarah GeorgiadouOlga TsachouridouVasileios PetrakisKonstantinos TsiakosMaria KosmidouVassiliki LygouraMaria DareiotiHaralampos MilionisIlias C PapanikolaouKarolina AkinosoglouDimitra-Melia MyrodiaAreti GravvaniAliki StamouTheologia GkavogianniKonstantina KatriniTheodoros MarantosIoannis P TrontzasKonstantinos SyrigosLoukas G ChatzisStamatios ChatzisNikolaos VechlidisChristina AvgoustouStamatios ChalvatzisMiltiades KyprianouJos Wm van der MeerJesper Eugen-OlsenMihai G NeteaEvangelos J Giamarellos-Bourboulis

Published in: eLife (2021)

NCT04357366.

Keyphrases

respiratory failure
coronavirus disease
sars cov
extracorporeal membrane oxygenation
mechanical ventilation
phase iii
study protocol
phase ii
clinical trial
acute respiratory distress syndrome
respiratory syndrome coronavirus
randomized controlled trial
intensive care unit